Format

Send to

Choose Destination
Cell Cycle. 2004 Dec;3(12):1477-80. Epub 2004 Dec 4.

Epithelial-mesenchymal transition: NF-kappaB takes center stage.

Author information

1
Research Institute of Molecular Pathology, Vienna, Austria.

Abstract

Activation of the transcription factor NF-kappaB occurs in many human tumors, and studies have shown that NF-kappaB can promote cell proliferation and oncogenesis, possibly by protecting cells from apoptosis. Little is known, however, about whether NF-kappaB is involved in tumor progression including epithelial-mesenchymal transition (EMT), a central process governing both morphogenesis and carcinoma progression in multicellular organisms. In a combined in vitro/in vivo model of mammary carcinogenesis, NF-kappaB was essential both for the induction and maintenance of EMT and for in vivo metastasis. NF-kappaB and the signaling pathways that are involved in its activation should therefore receive attention as potential targets for the development of novel anti-metastatic cancer treatments.

PMID:
15539952
DOI:
10.4161/cc.3.12.1280
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center